MeSH term
Frequency | Condition_Probility | Female | 107 | 0.0 |
Humans | 291 | 0.0 |
Pregnancy | 3 | 0.0 |
Animals | 176 | 0.0 |
COS Cells | 20 | 0.0 |
Cyclic AMP/metabolism | 35 | 6.0 |
GTP-Binding Protein alpha Subunits, Gs/*genetics/metabolism | 2 | 66.0 |
In Vitro | 7 | 0.0 |
Inositol Phosphates/metabolism | 5 | 3.0 |
Mutation/genetics | 4 | 0.0 |
Receptors, Thyrotropin/*genetics/metabolism | 5 | 100.0 |
Research Support, Non-U.S. Gov't | 187 | 0.0 |
Autoantibodies/*immunology | 13 | 5.0 |
Epitopes/immunology | 8 | 1.0 |
Receptors, Thyrotropin/*immunology | 28 | 77.0 |
Cell Line | 32 | 0.0 |
Cytokines/*biosynthesis | 2 | 0.0 |
Child | 11 | 0.0 |
Child, Preschool | 9 | 0.0 |
Flow Cytometry | 18 | 0.0 |
*Germ-Line Mutation | 5 | 1.0 |
Infant | 9 | 0.0 |
Infant, Newborn | 11 | 0.0 |
Male | 84 | 0.0 |
Receptors, Thyrotropin/*genetics | 55 | 90.0 |
Thyrotropin/blood | 4 | 1.0 |
Adipocytes/pathology | 2 | 20.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Cells, Cultured | 27 | 0.0 |
Graves' Disease/*metabolism/*pathology | 2 | 50.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
Receptors, Thyrotropin/drug effects/genetics/*metabolism | 3 | 75.0 |
Research Support, U.S. Gov't, P.H.S. | 88 | 0.0 |
*Disease Models, Animal | 9 | 2.0 |
Mice | 65 | 0.0 |
Mice, Inbred BALB C | 28 | 0.0 |
Mice, Inbred NOD | 3 | 1.0 |
Gene Expression/immunology | 2 | 2.0 |
Receptors, Thyrotropin/*genetics/*immunology | 3 | 100.0 |
Adult | 52 | 0.0 |
Aged | 18 | 0.0 |
Autoantibodies/*analysis | 6 | 2.0 |
CHO Cells | 50 | 2.0 |
Graves' Disease/*immunology | 23 | 27.0 |
Hamsters | 56 | 1.0 |
Middle Aged | 46 | 0.0 |
Amino Acid Substitution | 5 | 0.0 |
Models, Molecular | 7 | 0.0 |
Mutagenesis, Site-Directed | 12 | 0.0 |
Protein Conformation | 7 | 0.0 |
Receptors, Thyrotropin/genetics/*metabolism | 9 | 90.0 |
Structure-Activity Relationship | 11 | 0.0 |
Thyrotropin/*metabolism | 8 | 36.0 |
Transfection | 46 | 0.0 |
Amino Acid Sequence | 59 | 0.0 |
Molecular Sequence Data | 65 | 0.0 |
Receptors, Thyrotropin/*chemistry/*genetics/metabolism | 2 | 100.0 |
Epitopes | 10 | 1.0 |
Graves' Disease/immunology | 12 | 27.0 |
Hypothyroidism/*immunology | 3 | 30.0 |
Immunoglobulin G/immunology | 5 | 1.0 |
Neutralization Tests | 5 | 1.0 |
Peptide Fragments/immunology | 9 | 3.0 |
Receptors, Thyrotropin/genetics/*immunology | 6 | 85.0 |
Alleles | 11 | 0.0 |
*Genetic Predisposition to Disease | 3 | 0.0 |
Genotype | 6 | 0.0 |
Graves' Disease/*genetics | 6 | 16.0 |
Heterozygote | 10 | 0.0 |
Polymorphism, Genetic | 8 | 0.0 |
Disease Models, Animal | 14 | 0.0 |
Mice, Inbred C57BL | 7 | 0.0 |
Mice, Inbred CBA | 4 | 1.0 |
Thyroid Gland/pathology | 8 | 25.0 |
*Mutation | 20 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Thyrotropin/*physiology | 3 | 27.0 |
Antibodies | 3 | 0.0 |
Antibodies, Monoclonal | 6 | 0.0 |
Antibody Specificity | 14 | 1.0 |
Graves' Disease/metabolism | 6 | 30.0 |
Immunohistochemistry | 11 | 0.0 |
Thyroid Gland/*chemistry | 3 | 21.0 |
Receptors, Thyrotropin/*metabolism | 8 | 88.0 |
Thyroid Nodule/*physiopathology | 2 | 100.0 |
Thyrotropin/*pharmacology | 9 | 31.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Autoantibodies/biosynthesis | 3 | 8.0 |
Cats | 2 | 0.0 |
Cloning, Molecular | 12 | 0.0 |
Radioligand Assay | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 10 | 0.0 |
Antibodies/*immunology | 2 | 1.0 |
Cyclic AMP/biosynthesis | 15 | 12.0 |
Gene Expression/drug effects | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Gene Frequency | 8 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Blotting, Western | 14 | 0.0 |
Cell Membrane/metabolism | 8 | 0.0 |
Cell Separation | 4 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Dimerization | 3 | 0.0 |
Dose-Response Relationship, Drug | 6 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 6 | 0.0 |
Green Fluorescent Proteins | 4 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Protein Binding | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Gene Expression | 18 | 0.0 |
Hyperthyroidism/*genetics | 4 | 66.0 |
Pedigree | 11 | 0.0 |
Thyrotropin/pharmacology | 19 | 31.0 |
Carrier Proteins/genetics | 3 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 14 | 4 | 2.0 |
Genetic Markers | 4 | 0.0 |
Linkage (Genetics) | 5 | 0.0 |
Membrane Proteins/genetics | 3 | 0.0 |
Receptors, Thyrotropin/genetics | 15 | 60.0 |
Thyroid Neoplasms/*genetics | 4 | 4.0 |
Iodine Radioisotopes/diagnostic use | 10 | 3.0 |
Protein Structure, Tertiary | 9 | 0.0 |
Thyroid Gland/immunology | 3 | 7.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
Binding Sites | 12 | 0.0 |
Fluorescence Recovery After Photobleaching | 2 | 11.0 |
Receptors, Thyrotropin/*chemistry/immunology/*metabolism | 2 | 100.0 |
Thyrotropin/metabolism/pharmacology | 4 | 100.0 |
Binding Sites, Antibody | 5 | 1.0 |
Enzyme-Linked Immunosorbent Assay | 15 | 0.0 |
Immunoglobulin G/metabolism | 4 | 2.0 |
*Peptide Library | 3 | 5.0 |
Receptors, Thyrotropin/immunology | 4 | 22.0 |
Codon/genetics | 3 | 0.0 |
GTP-Binding Protein alpha Subunits, Gs/*genetics | 4 | 33.0 |
Mutation/*genetics | 3 | 0.0 |
Polymerase Chain Reaction | 25 | 0.0 |
Receptors, Thyrotropin/chemistry/*genetics | 5 | 100.0 |
Thyroid Nodule/*genetics | 3 | 75.0 |
Blotting, Southern | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Myocardium/*metabolism | 2 | 0.0 |
RNA, Messenger/*analysis | 3 | 0.0 |
Adipocytes/*metabolism | 2 | 4.0 |
Cell Differentiation | 8 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
*Gene Expression | 7 | 0.0 |
Orbit/*pathology | 2 | 40.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Stem Cells/metabolism | 2 | 2.0 |
Immunosorbent Techniques | 2 | 0.0 |
Recombinant Proteins/immunology | 8 | 2.0 |
Thyroiditis, Autoimmune/immunology | 4 | 11.0 |
Thyrotropin/metabolism | 26 | 46.0 |
Evolution | 2 | 0.0 |
Antigen Presentation | 2 | 0.0 |
Autoantigens/*metabolism | 2 | 8.0 |
Carbohydrates/analysis | 2 | 3.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Thyroiditis, Autoimmune/*immunology | 4 | 5.0 |
Binding, Competitive | 9 | 0.0 |
Codon | 6 | 1.0 |
Cross-Linking Reagents | 2 | 0.0 |
Ligands | 5 | 0.0 |
Mutagenesis | 3 | 0.0 |
Mutation | 13 | 0.0 |
Rats | 23 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Osmolar Concentration | 2 | 0.0 |
Reference Values | 9 | 0.0 |
Thyroid Gland/metabolism | 12 | 22.0 |
Thyroid Nodule/*metabolism | 2 | 50.0 |
Receptors, Thyrotropin/*chemistry | 3 | 75.0 |
Epitope Mapping | 4 | 1.0 |
Epitopes/*chemistry/*immunology | 2 | 66.0 |
Receptors, Thyrotropin/*chemistry/*immunology | 2 | 100.0 |
Species Specificity | 6 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Signal Transduction | 9 | 0.0 |
Chromatography, Affinity | 6 | 0.0 |
Drug Stability | 2 | 0.0 |
*Protein Conformation | 2 | 0.0 |
Receptors, Thyrotropin/*chemistry/genetics/*immunology | 4 | 100.0 |
Autoantibodies/*blood | 7 | 2.0 |
Diagnosis, Differential | 2 | 0.0 |
Iodide Peroxidase/immunology | 3 | 5.0 |
Retrospective Studies | 2 | 0.0 |
Syndrome | 3 | 0.0 |
*Antibodies, Monoclonal | 2 | 0.0 |
Glycosylation | 10 | 1.0 |
Iodine Radioisotopes | 3 | 0.0 |
Peptide Fragments/chemistry/immunology | 3 | 5.0 |
Receptors, Thyrotropin/genetics/*immunology/metabolism | 2 | 100.0 |
Recombinant Fusion Proteins/immunology | 5 | 4.0 |
Point Mutation | 2 | 0.0 |
Autoantibodies/blood | 8 | 4.0 |
Case-Control Studies | 7 | 0.0 |
Base Sequence | 33 | 0.0 |
DNA Primers | 7 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Adenoviridae/genetics | 5 | 1.0 |
Antibodies/blood | 2 | 3.0 |
Disease Susceptibility | 2 | 0.0 |
Incidence | 3 | 0.0 |
Cattle | 8 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Molecular Weight | 8 | 0.0 |
Protein Subunits | 3 | 0.0 |
Receptors, Thyrotropin/*biosynthesis | 4 | 100.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
Recombinant Proteins/pharmacology | 5 | 0.0 |
Histocompatibility Antigens Class I/immunology | 2 | 1.0 |
Histocompatibility Antigens Class II/genetics/immunology | 2 | 10.0 |
Thyrotropin/immunology | 5 | 83.0 |
Antibody Formation | 6 | 1.0 |
Epitopes, T-Lymphocyte/immunology | 2 | 2.0 |
Fibroblasts/immunology | 3 | 4.0 |
Immunization | 16 | 4.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Comparative Study | 27 | 0.0 |
Lymphocyte Activation | 4 | 0.0 |
Mice, Inbred AKR | 4 | 8.0 |
Immunoglobulins, Thyroid-Stimulating/*immunology/metabolism | 2 | 100.0 |
Iodine Radioisotopes/*therapeutic use | 2 | 6.0 |
Autoantibodies/blood/*immunology | 2 | 5.0 |
Thyroid Function Tests | 4 | 4.0 |
Thyrotropin/metabolism/*pharmacology | 7 | 100.0 |
DNA Mutational Analysis | 7 | 0.0 |
Family Health | 3 | 0.0 |
Germ-Line Mutation | 4 | 1.0 |
*Point Mutation | 10 | 0.0 |
Antigens, Differentiation/*genetics | 4 | 2.0 |
Genetic Predisposition to Disease | 5 | 0.0 |
*Immunoconjugates | 5 | 1.0 |
Japan | 4 | 0.0 |
*Microsatellite Repeats | 2 | 0.0 |
Adolescent | 17 | 0.0 |
Adipose Tissue/*metabolism/pathology | 2 | 40.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Graves' Disease/*genetics/immunology | 2 | 18.0 |
DNA, Complementary | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Receptors, Thyrotropin/chemistry/*genetics/metabolism | 2 | 100.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Analysis, DNA | 7 | 0.0 |
GTP-Binding Proteins/metabolism | 4 | 1.0 |
Gene Deletion | 5 | 0.0 |
Cyclic AMP/*physiology | 2 | 2.0 |
Receptors, Thyrotropin/chemistry/*genetics/physiology | 2 | 100.0 |
Thyroid Neoplasms/*genetics/metabolism | 2 | 12.0 |
Transcription, Genetic | 6 | 0.0 |
DNA/analysis | 4 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Restriction Mapping | 5 | 0.0 |
Abdomen | 2 | 2.0 |
Cercopithecus aethiops | 9 | 0.0 |
Cricetulus | 4 | 0.0 |
Adenoma/genetics | 3 | 6.0 |
GTP-Binding Protein alpha Subunits, Gs/genetics | 4 | 44.0 |
Hyperplasia | 2 | 0.0 |
Thyroid Neoplasms/genetics | 3 | 10.0 |
Immunoglobulins, Thyroid-Stimulating/*blood | 4 | 66.0 |
Recombinant Proteins/immunology/metabolism | 3 | 6.0 |
Swine | 8 | 0.0 |
Carcinoma/*metabolism | 2 | 2.0 |
Cell Division/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Thyroglobulin/genetics | 4 | 21.0 |
Thyroid Neoplasms/*metabolism | 4 | 10.0 |
Trans-Activators/genetics | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Autoantibodies/*biosynthesis | 3 | 5.0 |
Graves' Disease/etiology/*immunology/pathology | 2 | 66.0 |
Th2 Cells/immunology | 3 | 1.0 |
Thyroxine/blood | 10 | 3.0 |
Exons | 7 | 0.0 |
Graves' Disease/pathology/*physiopathology | 2 | 50.0 |
*Mice | 2 | 33.0 |
Biotinylation | 2 | 1.0 |
Hela Cells | 3 | 0.0 |
Receptors, Thyrotropin/analysis/*immunology | 2 | 100.0 |
Antibodies, Monoclonal/immunology | 4 | 0.0 |
Hydrolysis | 3 | 0.0 |
Receptors, Thyrotropin/chemistry/genetics/*metabolism | 3 | 100.0 |
Polymorphism, Single-Stranded Conformational | 8 | 0.0 |
Thyroidectomy | 5 | 3.0 |
Adoptive Transfer | 3 | 3.0 |
Peptide Fragments/biosynthesis/genetics/immunology | 2 | 66.0 |
Solubility | 4 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Phenotype | 7 | 0.0 |
Recombinant Proteins | 7 | 0.0 |
Autoantigens/chemistry/genetics | 2 | 50.0 |
Escherichia coli/genetics | 4 | 0.0 |
L Cells (Cell Line) | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/immunology | 2 | 20.0 |
DNA, Complementary/*genetics | 2 | 0.0 |
English Abstract | 9 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Receptors, Thyrotropin/biosynthesis/*genetics | 2 | 66.0 |
*Transfection | 3 | 1.0 |
Organ Specificity | 3 | 0.0 |
Receptors, Thyrotropin/drug effects/*genetics/metabolism | 2 | 100.0 |
Retroviridae/genetics | 2 | 0.0 |
*Symporters | 4 | 4.0 |
Thyroglobulin/immunology | 2 | 3.0 |
Graves' Disease | 2 | 66.0 |
Carcinoma, Papillary/metabolism | 2 | 18.0 |
Statistics, Nonparametric | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Receptors, Thyrotropin/genetics/immunology/*metabolism | 2 | 100.0 |
Cysteine/metabolism | 2 | 2.0 |
Dogs | 4 | 0.0 |
Graves' Disease/blood/*immunology | 3 | 33.0 |
Methionine/metabolism | 2 | 1.0 |
Sulfur Radioisotopes | 2 | 2.0 |
Adenocarcinoma, Follicular/*genetics/pathology | 2 | 50.0 |
Adenylate Cyclase/metabolism | 3 | 2.0 |
Exons/genetics | 2 | 0.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Goiter, Nodular/*genetics | 2 | 40.0 |
Thyroid Gland/*pathology | 2 | 14.0 |
Biopsy, Needle | 2 | 0.0 |
Temperature | 2 | 0.0 |
Thyroglobulin/*immunology | 2 | 2.0 |
Thyroid Gland/cytology/metabolism | 2 | 25.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Epitopes/*immunology | 2 | 0.0 |
Antibodies, Blocking/immunology | 2 | 11.0 |
Rabbits | 6 | 0.0 |
Vaccination | 2 | 1.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Graves' Disease/genetics | 2 | 25.0 |
Proline/genetics | 2 | 3.0 |
Antibodies, Monoclonal/*immunology | 4 | 0.0 |
Culture Media, Conditioned | 2 | 0.0 |
Peptide Fragments/*immunology | 3 | 2.0 |
Iodine Radioisotopes/therapeutic use | 2 | 5.0 |
Genetic Vectors | 6 | 0.0 |
Culture Media | 3 | 0.0 |
Biological Markers | 3 | 0.0 |
Iodide Peroxidase/genetics | 2 | 18.0 |
Recurrence | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Thyroid Neoplasms/*genetics/pathology | 2 | 6.0 |
Amino Acid Sequence/genetics | 2 | 0.0 |
GTP-Binding Proteins/*metabolism | 2 | 0.0 |
Orbit/*metabolism | 3 | 75.0 |
Prevalence | 2 | 0.0 |
Baculoviridae/genetics | 3 | 1.0 |
Binding Sites, Antibody/immunology | 2 | 13.0 |
Immunoglobulin Isotypes/immunology | 2 | 6.0 |
Blotting, Northern | 8 | 0.0 |
Down-Regulation | 2 | 0.0 |
RNA, Messenger/*metabolism | 4 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Cyclic AMP/*metabolism | 5 | 2.0 |
Triiodothyronine/blood | 4 | 1.0 |
Thyroid Gland/immunology/pathology | 2 | 66.0 |
Graves' Disease/*immunology/pathology | 2 | 28.0 |
Receptors, Thyrotropin/*genetics/immunology | 3 | 60.0 |
Time Factors | 4 | 0.0 |
Autoantibodies/immunology | 4 | 3.0 |
RNA-Directed DNA Polymerase | 2 | 1.0 |
Immunoglobulins, Fab/immunology | 2 | 1.0 |
Receptors, Thyrotropin/*immunology/metabolism | 3 | 100.0 |
Autoantigens/immunology | 4 | 2.0 |
Cell Division/physiology | 2 | 0.0 |
Thyrotropin/physiology | 2 | 22.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Azo Compounds | 2 | 20.0 |
Dyes | 2 | 1.0 |
Receptors, Thyrotropin/immunology/*metabolism | 2 | 100.0 |
Staining and Labeling | 2 | 0.0 |
DNA/analysis/genetics | 2 | 1.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Receptors, Thyrotropin/*analysis/*genetics | 3 | 100.0 |
Binding Sites/immunology | 2 | 3.0 |
Receptors, Thyrotropin/chemistry/*immunology | 4 | 100.0 |
Thyroid Gland/*immunology | 5 | 8.0 |
Vaccines, DNA/*immunology | 4 | 14.0 |
*Genes, Dominant | 2 | 0.0 |
GTP-Binding Proteins/genetics | 2 | 4.0 |
Drug Resistance/genetics | 2 | 1.0 |
Endocrine Glands/physiopathology | 2 | 18.0 |
Thyroid Gland/physiopathology | 3 | 15.0 |
Autoantibodies/*metabolism | 5 | 27.0 |
*Chromosome Mapping | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Myxedema/immunology | 3 | 60.0 |
Receptors, Thyrotropin/chemistry/*genetics/immunology | 2 | 100.0 |
Recombinant Proteins/metabolism | 6 | 0.0 |
Iodide Peroxidase/genetics/metabolism | 2 | 100.0 |
Thyroglobulin/genetics/metabolism | 2 | 100.0 |
Adipose Tissue/*metabolism | 2 | 1.0 |
Orbit | 2 | 33.0 |
Receptors, Thyrotropin/*chemistry/*physiology | 2 | 100.0 |
Graves' Disease/blood/immunology | 3 | 60.0 |
*Transcription, Genetic | 2 | 0.0 |
Antibodies, Blocking/metabolism | 2 | 40.0 |
Antigen-Antibody Reactions | 3 | 0.0 |
*Protein Structure, Tertiary | 3 | 2.0 |
Iodide Peroxidase/*immunology | 3 | 4.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Antibodies/analysis | 3 | 2.0 |
Recombinant Fusion Proteins/genetics/immunology | 2 | 4.0 |
*Epitopes | 2 | 1.0 |
Immunoglobulins, Thyroid-Stimulating/*immunology | 2 | 66.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Genes, myc | 3 | 1.0 |
Kinetics | 8 | 0.0 |
Antibodies, Bacterial/immunology | 2 | 4.0 |
Cross Reactions | 4 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
3T3 Cells | 3 | 0.0 |
DNA Probes | 3 | 0.0 |
DNA/chemistry/metabolism | 2 | 2.0 |
Thyroxine/metabolism | 2 | 8.0 |
Crosses, Genetic | 2 | 0.0 |
Genes, ras | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
RNA, Neoplasm/chemistry/genetics | 2 | 25.0 |
Trans-Activators/genetics/metabolism | 2 | 1.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Autoantibodies/metabolism | 4 | 21.0 |
Plasmids | 3 | 0.0 |
Hyperthyroxinemia/*immunology | 2 | 100.0 |
Mice, Inbred Strains | 5 | 0.0 |
Cell Membrane/chemistry | 2 | 1.0 |
Kidney | 3 | 0.0 |
Autoantibodies/*pharmacology | 2 | 22.0 |
Receptors, Thyrotropin/genetics/metabolism | 2 | 66.0 |
*Lymphocyte Activation | 2 | 0.0 |
Adenylate Cyclase/*metabolism | 3 | 5.0 |
Second Messenger Systems | 2 | 2.0 |
Immunoglobulins, Thyroid-Stimulating/analysis | 2 | 66.0 |
Immunoglobulins, Thyroid-Stimulating/immunology | 2 | 50.0 |
Phosphatidylinositols/*metabolism | 2 | 2.0 |
*Protein Structure, Secondary | 3 | 2.0 |
*Signal Transduction | 8 | 0.0 |
Receptors, Thyrotropin/*physiology | 2 | 66.0 |
Receptors, Thyrotropin/antagonists & inhibitors/*immunology | 2 | 100.0 |
Cyclic AMP/physiology | 2 | 1.0 |
Enzyme Activation | 4 | 0.0 |
Receptors, Thyrotropin/chemistry/*metabolism | 2 | 100.0 |
Simian virus 40/genetics | 2 | 1.0 |
Immunoglobulin G/pharmacology | 4 | 6.0 |
Immunoglobulins, Thyroid-Stimulating | 7 | 29.0 |
Phosphatidylinositol 4,5-Diphosphate | 2 | 12.0 |
Yersinia enterocolitica/*immunology | 2 | 20.0 |
Thyrotropin/*metabolism/pharmacology | 3 | 50.0 |
Hypothyroidism/*genetics | 3 | 27.0 |
Peptide Fragments/chemical synthesis/*immunology | 2 | 25.0 |
Threonine | 2 | 3.0 |
Models, Biological | 3 | 0.0 |
Receptors, LH/genetics/*metabolism | 2 | 25.0 |
Cell Division | 2 | 0.0 |
Thyroid Gland/*metabolism | 2 | 4.0 |
Thyroid Hormones/blood | 2 | 2.0 |
DNA/genetics | 2 | 0.0 |
Receptors, Thyrotropin/blood/*immunology | 2 | 100.0 |
Mice, Transgenic | 2 | 0.0 |
Receptors, Thyrotropin/immunology/metabolism | 2 | 66.0 |
Mice, Knockout | 4 | 0.0 |
Luminescent Proteins/genetics | 2 | 1.0 |
Heterotrimeric GTP-Binding Proteins/metabolism | 2 | 5.0 |
Receptors, Thyrotropin/*genetics/*metabolism | 3 | 100.0 |
Microscopy, Confocal | 3 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
European Continental Ancestry Group | 2 | 0.0 |
Animals, Outbred Strains | 2 | 18.0 |
Binding, Competitive/immunology | 2 | 2.0 |
